CO5150208A1 - Compuestos de dihidropiridina ciclopentanona utiles como abridores de canales de potasio - Google Patents
Compuestos de dihidropiridina ciclopentanona utiles como abridores de canales de potasioInfo
- Publication number
- CO5150208A1 CO5150208A1 CO00014719A CO00014719A CO5150208A1 CO 5150208 A1 CO5150208 A1 CO 5150208A1 CO 00014719 A CO00014719 A CO 00014719A CO 00014719 A CO00014719 A CO 00014719A CO 5150208 A1 CO5150208 A1 CO 5150208A1
- Authority
- CO
- Colombia
- Prior art keywords
- group
- alkyl
- haloalkyl
- hydrogen
- dihydropiridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto que tiene la fórmula I<EMI FILE="00014719_1" ID="1" IMF=JPEG >o una sal, ester o amida del mismo farmacéuticamente aceptable, en donde la línea punteada representa la presencia de un enlace doble opcional; R1 es seleccionado del grupo que consiste de arilo y heteroarilo; A es seleccionado del grupo que consiste de hidrógeno, alquil, ciano, haloalquil, heteroaril, nitro y -C(O)R2, en donde R2 es seleccionado del grupo que consiste de alquil, haloalquil e hidroxi; R3 es seleccionado del grupo que consiste de hidrógeno, alquil y haloalquil; y A y R3 tomado juntos con el anillo al cual están unidos pueden formar un anillo carbocíclico de 5 o 6 miembros, dicho anillo carbocíclico de 5 o 6 miembros puede contener 1 o 2 enlaces dobles y puede ser substituido con 1 o 2 substituyentes seleccionados del grupo que consiste de hidrógeno, alquenil, alcoxi, alcoxialcoxi, alcoxialquil, alquil, alquinil, arilalcoxi, haloalquenil, haloalquil, halógeno, hidroxi, hidroxialquenil, hidroxialquil, oxo, y -NR4R5 en donde R4 y R5 son seleccionados independientemente del grupo que consiste de hidrógeno y alquilo C1-C4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/262,441 US6518279B2 (en) | 1999-03-04 | 1999-03-04 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5150208A1 true CO5150208A1 (es) | 2002-04-29 |
Family
ID=22997528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00014719A CO5150208A1 (es) | 1999-03-04 | 2000-03-01 | Compuestos de dihidropiridina ciclopentanona utiles como abridores de canales de potasio |
Country Status (20)
Country | Link |
---|---|
US (1) | US6518279B2 (es) |
EP (1) | EP1075466A1 (es) |
JP (1) | JP2003517454A (es) |
KR (1) | KR20010043295A (es) |
CN (1) | CN1318053A (es) |
AR (1) | AR028987A1 (es) |
AU (1) | AU3616800A (es) |
BG (1) | BG104999A (es) |
BR (1) | BR0005189A (es) |
CA (1) | CA2330541A1 (es) |
CO (1) | CO5150208A1 (es) |
HU (1) | HUP0102895A3 (es) |
IL (1) | IL139140A0 (es) |
MX (1) | MXPA00010790A (es) |
NO (1) | NO20005570L (es) |
PL (1) | PL343883A1 (es) |
SK (1) | SK18152000A3 (es) |
TR (1) | TR200003202T1 (es) |
WO (1) | WO2000051986A1 (es) |
ZA (1) | ZA200005798B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
US7074931B2 (en) | 2000-08-02 | 2006-07-11 | Astrazeneca Ab | Process for asymmetric synthesis of substituted 1,4 -dihydropyridines |
US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
US20030199578A1 (en) * | 2002-04-19 | 2003-10-23 | Turner Sean C. | Naphthalene amides as potassium channel openers |
JP2009526079A (ja) | 2006-02-10 | 2009-07-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | カリウムチャンネル開放物質としての新規な三環式ジヒドロピラジン |
JP5638011B2 (ja) | 2009-02-18 | 2014-12-10 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 二および三環式インダゾール置換1,4−ジヒドロピリジン誘導体およびそれらの使用 |
WO2021253180A1 (en) * | 2020-06-15 | 2021-12-23 | Novartis Ag | Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators |
US11939316B1 (en) | 2023-11-06 | 2024-03-26 | King Faisal University | 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound |
US11970478B1 (en) | 2023-11-16 | 2024-04-30 | King Faisal University | 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (de) | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
DE3447170A1 (de) | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
GB8716971D0 (en) | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Therapeutic agents |
GB8907401D0 (en) | 1989-04-01 | 1989-05-17 | Pfizer Ltd | Therapeutic agents |
ATE161531T1 (de) | 1991-10-21 | 1998-01-15 | Zeneca Ltd | Acridine-1,8-dionderivate als therapeutisches mittel |
GB9220570D0 (en) | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
GB9318935D0 (en) | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
DE4313690A1 (de) | 1993-04-27 | 1994-11-03 | Bayer Ag | Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |
WO1999031059A1 (en) | 1997-12-18 | 1999-06-24 | Abbott Laboratories | Potassium channel openers |
-
1999
- 1999-03-04 US US09/262,441 patent/US6518279B2/en not_active Expired - Fee Related
-
2000
- 2000-03-01 CO CO00014719A patent/CO5150208A1/es unknown
- 2000-03-02 AR ARP000100931A patent/AR028987A1/es not_active Application Discontinuation
- 2000-03-06 PL PL00343883A patent/PL343883A1/xx not_active Application Discontinuation
- 2000-03-06 BR BR0005189-6A patent/BR0005189A/pt not_active IP Right Cessation
- 2000-03-06 JP JP2000602213A patent/JP2003517454A/ja not_active Withdrawn
- 2000-03-06 HU HU0102895A patent/HUP0102895A3/hu unknown
- 2000-03-06 CN CN00800760A patent/CN1318053A/zh active Pending
- 2000-03-06 IL IL13914000A patent/IL139140A0/xx unknown
- 2000-03-06 TR TR2000/03202T patent/TR200003202T1/xx unknown
- 2000-03-06 SK SK1815-2000A patent/SK18152000A3/sk unknown
- 2000-03-06 CA CA002330541A patent/CA2330541A1/en not_active Abandoned
- 2000-03-06 EP EP00914832A patent/EP1075466A1/en not_active Withdrawn
- 2000-03-06 MX MXPA00010790A patent/MXPA00010790A/es unknown
- 2000-03-06 WO PCT/US2000/005828 patent/WO2000051986A1/en not_active Application Discontinuation
- 2000-03-06 AU AU36168/00A patent/AU3616800A/en not_active Abandoned
- 2000-03-06 KR KR1020007012257A patent/KR20010043295A/ko not_active Application Discontinuation
- 2000-10-18 ZA ZA200005798A patent/ZA200005798B/en unknown
- 2000-11-03 NO NO20005570A patent/NO20005570L/no not_active Application Discontinuation
- 2000-11-28 BG BG104999A patent/BG104999A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000051986A1 (en) | 2000-09-08 |
US20020007065A1 (en) | 2002-01-17 |
PL343883A1 (en) | 2001-09-10 |
MXPA00010790A (es) | 2002-06-04 |
AU3616800A (en) | 2000-09-21 |
HUP0102895A3 (en) | 2002-01-28 |
CA2330541A1 (en) | 2000-09-08 |
EP1075466A1 (en) | 2001-02-14 |
NO20005570D0 (no) | 2000-11-03 |
AR028987A1 (es) | 2003-06-04 |
BR0005189A (pt) | 2001-01-09 |
JP2003517454A (ja) | 2003-05-27 |
BG104999A (en) | 2001-10-31 |
HUP0102895A2 (hu) | 2001-12-28 |
NO20005570L (no) | 2000-11-03 |
ZA200005798B (en) | 2002-01-18 |
IL139140A0 (en) | 2001-11-25 |
TR200003202T1 (tr) | 2001-08-21 |
SK18152000A3 (sk) | 2001-06-11 |
US6518279B2 (en) | 2003-02-11 |
CN1318053A (zh) | 2001-10-17 |
KR20010043295A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5390047A1 (es) | Derivados de uk-2a | |
CO5611139A2 (es) | Pirimidinas aril sustituidas y el uso de las mismas | |
CO5200785A1 (es) | Uso terapeutico de quinazolina | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
YU48390B (sh) | Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate | |
CO5310534A1 (es) | Nuevos derivados de androstano anti-inflamatorios | |
CO5640117A2 (es) | Derivados de 2,4-diamonopirimidina | |
CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
ES2185338T3 (es) | Derivados de fumagilol y procedimientos para su fabricacion. | |
AR031597A1 (es) | Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3 | |
CO5180557A1 (es) | Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas . | |
CO5080782A1 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa | |
EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
ATE235476T1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
UY26048A1 (es) | Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica | |
CO5150208A1 (es) | Compuestos de dihidropiridina ciclopentanona utiles como abridores de canales de potasio | |
MEP11508A (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
CO5650231A2 (es) | Derivados de 1-(alquilaminoalquil-pirrolidin-/piperidinil)-2,2-difenilacetamida como antagonistas del receptor muscarinico, su procedimiento de sintesis y composiciones farmaceuticas que los contienen | |
EP1429771A4 (en) | BICYCLIC COMPOUNDS AS AN INHIBITORS OF CHEMOKIN BINDING AT US28 | |
CO6341516A2 (es) | Composiciones pesticidas | |
AR023381A1 (es) | Nuevo derivado de tiazolbenzoimidazol | |
AR046753A1 (es) | Derivados de benzoxazina y usos de los mismos | |
AR041605A1 (es) | Compuesto 1- sustituido-4-nitroimidazol y metodo para preparar el mismo | |
ATE548042T1 (de) | Prostansäurederivate zur senkung des augeninnendrucks |